MedTrace Logo

Milled vs 3D-Printed Partial-Coverage Restorations in Endodontically Treated Molars

NCT07643311 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2026-06-11

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the clinical performance of Computer-Aided Design and Computer-Aided Manufacturing (CAD/CAM)-milled and 3D-printed composite resin partial-coverage restorations in endodontically treated molars.

The main questions it aims to answer are:

* Do 3D-printed composite resin partial-coverage restorations show similar clinical performance compared with CAD/CAM-milled composite resin restorations?
* Are there differences in survival, success rates, and complications between the two types of restorations over a 3-year follow-up period?

Researchers will compare CAD/CAM-milled composite resin restorations with 3D-printed composite resin restorations to evaluate their clinical performance.

Participants will:

* Receive a partial-coverage restoration (onlay or overlay) in an endodontically treated molar.
* Be randomly assigned to receive either a CAD/CAM-milled or a 3D-printed composite resin restoration.
* Attend follow-up visits at 12, 24, and 36 months.
* Undergo clinical evaluations by two blinded evaluators using the revised FDI criteria and standardized photographic documentation.

Conditions

  • Endodontically Treated Teeth

Interventions

DEVICE

Milled Composite Resin Onlay/Overlay Restoration

Indirect partial coverage restoration fabricated from milled composite resin blocks (HC Block, Shofu, Japan) and adhesively cemented on endodontically treated molars.

DEVICE

3D-Printed Composite Resin Onlay/Overlay Restoration

Indirect partial coverage restoration fabricated from 3D-printed composite resin (Rodin Sculpture, Pac-Dent, USA) and adhesively cemented on endodontically treated molars.

Sponsors & Collaborators

  • Hospital San Jose

    lead OTHER

Principal Investigators

  • Tomás Yoma Galleguillos, DDS · Hospital San José, Santiago, Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-29
Primary Completion
2030-05-31
Completion
2030-06-30

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07643311 on ClinicalTrials.gov